Delivery Order SPE2DB24D1205-SPE2DB24FCTMY

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 25, 2022 with a ceiling value of $11,841.12. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), which is a defense agency under the U.S. Department of Defense. The contract, valued at $5,225.04, is a delivery order under DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This IDC, valued up to $999,999,999.00 through December 2025, serves as the primary vehicle for...
This federal contract award is for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,015.98, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $5,437.04 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 20, 2024, with a completion date of September 23, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by Amerisourcebergen with the DLA...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 17, 2024, with a ceiling value of $5,816.70 and a completion date of October 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award is for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,741.68 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,637.22 fixed-price delivery order has an ultimate completion date of December 4, 2024 and was awarded on December 3, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside and represents an individual delivery order under a larger Indefinite...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,685.70 and a completion date of November 8, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,257.00 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 17, 2023. The contract was not set aside for...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTMY
    Delivery Order

This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical product to the Defense Logistics Agency (DLA). The award, with a ceiling value of $11,928.83, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation. Amerisourcebergen, as the prime contractor, will be responsible for supplying the specified pharmaceutical product to the DLA, which is a defense agency that provides logistics, acquisition, and technical services to the U.S. military.

Generated 11/7/24, 9:32 AM